Supporting the role of p53 and PTEN as tumor suppressors, the majority of ovarian carcinomas tested was positive for p53 (55%), as the antibody detects both wildtype and mutated forms of p53, and negative for PTEN expression (89%). This evidence concerns the gene TP53 and neoplasm.